Pfizer

15 Archived Projects

Title Investigator Start End
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance Hare
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Luetkemeyer
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis
A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy &Safety of Atorvastatin in Patients w/ Clinically Isolated Syndrome & High Risk for Conversion to M.S. Bluestone
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Chambers
Pfizer A4001027: Observational Phase Extension Luetkemeyer
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study
International Fellowship Program in Drug Development
Accelerating and Intensifying Tuberculosis Case Finding in Uganda Davis
Mycotic Ulcer Treatment Trial (MUTT) Acharya
ViiV Healthcare A4001098 Luetkemeyer
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance
QB3-UCSF Pfizer Collaboration Kelly
Effects of Maraviroc on HIV-related Kaposi Sarcoma Maurer